RSV Treatment

Covid-19 vaccine market worth $10bn a year, analysts say    Financial Times

Icosavax Launches COVID-19 Vaccine Program with Preclinical Data and $16.5 Million in New Funding    BioSpace

Efficacy of a Single-Dose Monoclonal Antibody Against RSV    AAP News

Reasons for optimism this flu season: vaccine, testing, masks - Washington Daily News    thewashingtondailynews.com

Icosavax Launches COVID-19 Vaccine Program with Preclinical Data and $16.5 Million in New Funding | Vaccines | News Channels    PipelineReview.com

Will SARS-CoV-2 become endemic?    Science Magazine

Codagenix, Inc. Appoints Jeffrey Fu, Ph.D., Chief Business Officer    PRNewswire

Flu activity still minimal in Wyoming; estimated 400K hospitalizations, 22K deaths in U.S. last season    Oil City News

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease    Wiley

Pfizer is on the verge of claiming a multibillion-dollar first-mover advantage with their Covid-19 vaccine — analyst    Endpoints News

Johnson & Johnson to supply EU with up to 400 million COVID-19 vaccine doses    BioPharma-Reporter.com

Other news to note for Oct. 8, 2020 | 2020-10-08    BioWorld Online

China Gives Unproven Covid-19 Vaccines to Thousands, With Risks Unknown    The New York Times

China Gives Unproven Covid-19 Vaccines to Thousands, With Risks Unknown    The New York Times

Michigan's GRAM Inks COVID-19 Vaccine Manufacturing Deal with J&J    BioSpace

Third of Parents Not Planning to Give Their Kids a Flu Shot This Year    Healthline

Odisha man arrested for manufacturing fake Covid-19 vaccine    Business Insider India

September 25 coronavirus news    CNN

Virometix Announces Completion of Initial Vaccination of the First Dose Cohort in Phase 1 Study with V-306    Business Wire

What will happen when COVID-19 and the flu collide this fall?    Anchorage Press